A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
Active, not recruiting · NCT06921850 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT06921850 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| UCB Biopharma SRL | 30 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hs0006 40095 | Wroclaw | Poland | 1 |
| Hs0006 40326 | Berlin | Germany | 1 |
| Hs0006 40625 | Lodz | Poland | 1 |
| Hs0006 40761 | Warsaw | Poland | 1 |
| Hs0006 40845 | Wroclaw | Poland | 1 |
| Hs0006 50178 | Clarkston | United States | 1 |
| Hs0006 50199 | Miami | United States | 1 |
| Hs0006 50201 | Arlington | United States | 1 |
| Hs0006 50202 | Fairborn | United States | 1 |
| Hs0006 50684 | Sacramento | United States | 1 |
| Hs0006 50706 | Chapel Hill | United States | 1 |
| Hs0006 50707 | Washington D.C. | United States | 1 |
| Hs0006 50708 | Roseville | United States | 1 |
| Hs0006 50710 | Fort Gratiot | United States | 1 |
| Hs0006 50711 | Troy | United States | 1 |
| Hs0006 50712 | Bowling Green | United States | 1 |